Seek revenue guidance for FY23 downgraded by 1.2% and shares fall by 5%

Nick Sundich Nick Sundich, April 4, 2023

Barely 6 weeks after it was issued, Seek’s revenue guidance for FY23 was cut. This led to a 5% sell-off in shares this morning, but it is still in positive territory in FY23.

 

No time to do stock research, but you still want to invest?

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

Seek revenue guidance cut from A$1.26bn to $1.245bn

Seek’s revenue guidance was only cut by 1.2%, from $1.26bn to $1.245bn. Shares in the company fell by 5% this morning. Despite today’s losses, shares are still up on a YTD basis.

 

Seek (ASX:SEK) share price chart, log scale (Source: TradingView)

 

An over-reaction?

You could argue this was an over-reaction given that its EBITDA and NPAT guidance was unchanged and reiterated. However, three things may be of concern to investors.

First, it gave a warning that job ad volumes were moderating. The company wasn’t specific beyond that general warning – it did not state the extent to which they were moderating and how long it was expected. Granted, it is clearly not too vehement if Seek’s revenue guidance is only being downgraded by 1%.

Second, the company’s unchanged EBITDA and NPAT guidance was assumed to be offset by lower than assumed operating expenditure. And third, the fact that the company’s guidance was downgraded so soon after it was iterated.

Ultimately, only time will tell if its guidance holds. But investors may be forgiven for being sceptical amidst 4-decade high inflation.

 

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

There’s no credit card needed – the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Kamala Harris stocks

Kamala Harris stocks: If Joe Biden’s VP wins the White House in 2024, which stocks will win?

With the US Presidential election now certain to be a Kamala Harris v Donald Trump showdown, we’ve looked at so-called…

South32

South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?

South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-2024, it is capped…

drug reimbursement

Here’s why drug reimbursement is so important for ASX healthcare stocks

Let’s take a look at the concept of drug reimbursement, something that is crucial for ASX healthcare stocks looking to…